mk 0663 has been researched along with Coxarthrosis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhverdyan, YR; Polyakova, JV; Sivordova, LE; Zavodovsky, BV | 1 |
| Bingham, CO; Bird, SR; Smugar, SS; Tershakovec, AM; Xu, X | 1 |
| Lesaffre, E | 2 |
| Derry, S; Gammaitoni, AR; Moore, OA; Moore, RA; Peloso, PM; Wang, H | 1 |
| Bingham, CO; Smugar, SS; Tershakovec, AM; Wang, H | 1 |
| Brunnekreef, JJ; Hoogervorst, P; Ploegmakers, MJ; Rijnen, WH; Schreurs, BW | 1 |
| Feldman, D; Gerli, R; Hou, SM; Ozturk, ZE; Rodger, IW; Scott, D; Uebelhart, D; Zacher, J | 1 |
| Bingham, CO; Bird, S; Fitzgerald, BJ; Kremer, J; O'Brien, K; Rubin, BR; Ruoff, GE; Sebba, AI; Smugar, SS; Tershakovec, AM | 1 |
| Beaulieu, A; Castro, R; Detora, LM; Gallacher, AE; Leung, AT; Malmstrom, K; Ng, J; Poor, G; Sanchez, M; Sarembock, B | 1 |
3 review(s) available for mk 0663 and Coxarthrosis
| Article | Year |
|---|---|
Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis.
Topics: Aged; Analysis of Variance; Celecoxib; Cyclooxygenase Inhibitors; Etoricoxib; Female; Health Status Indicators; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Sulfonamides; Sulfones; Treatment Outcome | 2008 |
Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice.
Topics: Cyclooxygenase 2 Inhibitors; Diffusion of Innovation; Dose-Response Relationship, Drug; Etoricoxib; Humans; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain; Pain Measurement; Pyridines; Randomized Controlled Trials as Topic; Sulfones; Treatment Outcome | 2010 |
Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo.
Topics: Aged; Celecoxib; Cyclooxygenase 2 Inhibitors; Epidemiologic Methods; Etoricoxib; Female; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Prognosis; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Sulfonamides; Sulfones; Time Factors; Treatment Outcome | 2009 |
5 trial(s) available for mk 0663 and Coxarthrosis
| Article | Year |
|---|---|
[Evidence of feasibility etoricoxib therapy in osteoarthritis in elderly patients].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Diclofenac; Drug Monitoring; Etoricoxib; Female; Humans; Male; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Management; Pyridines; Sulfones; Treatment Outcome | 2016 |
Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Etoricoxib; Female; Hip Joint; Hip Prosthesis; Humans; Male; Middle Aged; Ossification, Heterotopic; Osteoarthritis, Hip; Prospective Studies; Pyridines; Radiography; Severity of Illness Index; Sulfones; Treatment Outcome | 2013 |
A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Pyridines; Sulfones; Treatment Outcome; United States | 2003 |
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Male; Middle Aged; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Pyrazoles; Pyridines; Severity of Illness Index; Sulfonamides; Sulfones; Thrombosis; Treatment Outcome | 2007 |
Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial.
Topics: Cyclooxygenase 2; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Etoricoxib; Female; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Naproxen; Osteoarthritis, Hip; Osteoarthritis, Knee; Prostaglandin-Endoperoxide Synthases; Pyridines; Safety; Sulfones; Treatment Outcome | 2002 |
3 other study(ies) available for mk 0663 and Coxarthrosis
| Article | Year |
|---|---|
[Paracetamol in knee and hip arthrosis is dispensable].
Topics: Acetaminophen; Diclofenac; Etoricoxib; Humans; Naproxen; Osteoarthritis, Hip; Osteoarthritis, Knee; Pyridines; Sulfones; Treatment Outcome | 2016 |
Use and misuse of the p-value.
Topics: Biomedical Research; Celecoxib; Cyclooxygenase Inhibitors; Etoricoxib; Humans; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Sample Size; Statistics as Topic; Sulfonamides; Sulfones | 2008 |
Superiority, equivalence, and non-inferiority trials.
Topics: Celecoxib; Cyclooxygenase Inhibitors; Etoricoxib; Humans; Myocardial Infarction; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Statistics as Topic; Sulfonamides; Sulfones; Thrombolytic Therapy; Treatment Outcome | 2008 |